Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
50 mean » 20 means (Expand Search)
e fold » 5 fold (Expand Search), _ fold (Expand Search), 2 fold (Expand Search)
Showing 61 - 80 results of 10,876 for search '(((( 50 ((we decrease) OR (nn decrease)) ) OR ( e fold decrease ))) OR ( 50 mean decrease ))', query time: 0.48s Refine Results
  1. 61
    HA-MAD1 tumors have increased CIN and decreased p53.

    HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

    Published 2024
    Save to List
    Saved in:
  2. 62
    * months from treatment initiation.

    * months from treatment initiation. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 63
    Association between the slope of the ratio of the post-treatment RPR titer compared to the baseline titer and other characteristics using linear regression analysis.

    Association between the slope of the ratio of the post-treatment RPR titer compared to the baseline titer and other characteristics using linear regression analysis. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 64
    Temporal changes in the RPR titer from before to after treatment.

    Temporal changes in the RPR titer from before to after treatment. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 65
    The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from bladder cancer subjects.

    The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from... by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 66
    Heatmap showing the end motifs of ucfDNA among different groups.

    Heatmap showing the end motifs of ucfDNA among different groups. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 67
    Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups.

    Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 68
    ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples with the availability of creatinine measurements (38 controls versus 21 bladder cancer patients).

    ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples wi... by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 69
    Size distributions of ucfDNA molecules.

    Size distributions of ucfDNA molecules. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 70
    Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice.

    Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 71
    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay.

    DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup><i>-/-</i></sup> mice with quantifiable ucfDNA using Qubit assay. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 72
    Overview of the study design.

    Overview of the study design. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 73
    The end density of ucfDNA across different tissue types.

    The end density of ucfDNA across different tissue types. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 74
    End density of the ucfDNA fragments within the DHSs.

    End density of the ucfDNA fragments within the DHSs. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 75
    Percentages of ucfDNA fragments starting with T.

    Percentages of ucfDNA fragments starting with T. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 76
    Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset.

    Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 77
    S8 Fig -

    S8 Fig - by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 78
    DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup>-/-</sup> mice.

    DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i><sup>-/-</sup> and <i>Dnase1</i><sup>-/-</sup> mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 79
    S5 Fig -

    S5 Fig - by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 80
    Western blot and zymogram analysis of DNASE1 and DNASE1L3 in urine and plasma samples from healthy human subjects and C57BL/6 mice.

    Western blot and zymogram analysis of DNASE1 and DNASE1L3 in urine and plasma samples from healthy human subjects and C57BL/6 mice. by Meihui Chen (1670020)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: